Abstract #0185

Lanza G, Caruthers S, Williams T, Hockett F, Cyrus T, Allen J, Wickline S, Neubauer A

Fluorine magnetic resonance imaging, with its lack of competing background signal, has been used for a variety of applications including mapping oxygen tension, studying tumor metabolism, and imaging of vasculature and organ perfusion (1,2,3). In this work, we sought to characterize the use of a systemically-injected perfluoro-15-crown-5-ether fluorinated nanoparticle contrast agent for MR angiography at the clinical field strength 1.5 T.